MedTrace Logo

Predictors and Prognostic Factors of Gullian Barrie Syndrome Outcome

NCT04927598 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 62

Last updated 2022-12-08

No results posted yet for this study

Summary

This study aims to identify clinical and biological determinants and factors that predict outcome including primary outcome (percentage of changes in clinical scales pre- and after 3 months ) and secondary outcome depending on neurophysiologiacal studies and prognostic factors in individual patients with Guillain-Barre syndrome i individuals managed by plasmapheresis and IVIG immunoglobulin .

This information will be used to understand the diversity in clinical presentation and response to treatment of GBS.

Conditions

  • Guillain-Barre Syndrome

Interventions

DEVICE

plasmapheresis

patients of Gullian Barrie syndrome undergo plasmapharesis

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-20
Primary Completion
2021-10-15
Completion
2022-04-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04927598 on ClinicalTrials.gov